1. The protective role of p72 in doxorubicin-induced cardiomyocytes injury in vitro
   Bin Lin et al, 2016, Molecular Medicine Reports CrossRef
2. Panax notoginseng for Inflammation-Related Chronic Diseases: A Review on the Modulations of Multiple Pathways
   Yu Xu et al, 2018, The American Journal of Chinese Medicine CrossRef
3. Dose‐dependent exposure profile and metabolic characterization of notoginsenoside R1 in rat plasma by ultra‐fast liquid chromatography–electrospray ionization–tandem mass spectrometry
   Sainan Zhang et al, 2019, Biomedical Chromatography CrossRef
4. Traditional Chinese Medicine Monomers Are Potential Candidate Drugs for Cancer-Induced Cardiac Cachexia
   Zhizheng Li et al, 2024, Pharmacology CrossRef
5. Exploring the molecular mechanism of notoginsenoside R1 in sepsis-induced cardiomyopathy based on network pharmacology and experiments validation
   Ruifei Shao et al, 2023, Frontiers in Pharmacology CrossRef
6. GFI-1 Protects Against Lipopolysaccharide-Induced Inflammatory Responses and Apoptosis by Inhibition of the NF-κB/TNF-α Pathway in H9c2 Cells
   Yanlei Zheng et al, 2020, Inflammation CrossRef
7. Notoginsenoside R1–Induced Neuronal Repair in Models of Alzheimer Disease Is Associated With an Alteration in Neuronal Hyperexcitability, Which Is Regulated by Nav
   Tao Hu et al, 2020, Frontiers in Cellular Neuroscience CrossRef
8. Notoginsenoside R1, a unique constituent of Panax notoginseng, blinds proinflammatory monocytes to protect against cardiac hypertrophy in ApoE-/- mice
   Jing Xiao et al, 2018, European Journal of Pharmacology CrossRef
9. Notoginsenoside R1 improves intestinal microvascular functioning in sepsis by targeting Drp1-mediated mitochondrial quality imbalance
   Dongyao Hou et al, 2024, Pharmaceutical Biology CrossRef
10. Comparative Analysis of Panax ginseng Berries from Seven Cultivars Using UPLC-QTOF/MS and NMR-Based Metabolic Profiling
    Dahye Yoon et al, 2019, Biomolecules CrossRef
11. Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling
    Bin Zhang et al, 2018, Frontiers in Pharmacology CrossRef
12. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death
    Douglas B. Kell et al, 2015, Integrative Biology CrossRef
13. Notoginsenoside R1 protects hypoxia-reoxygenation deprivation-induced injury by upregulation of miR-132 in H9c2 cells
    Z Jin et al, 2021, Human & Experimental Toxicology CrossRef
14. Panax notoginseng saponins reduce high-risk factors for thrombosis through peroxisome proliferator-activated receptor -γ pathway
    Qin Shen et al, 2017, Biomedicine & Pharmacotherapy CrossRef
15. Total saponin extract, ginsenoside Rb1, and compound K alleviate peripheral and central neuropathic pain through estrogen receptors on rats
    Jee Youn Lee et al, 2021, Phytotherapy Research CrossRef
16. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction
    Han Li et al, 2022, Redox Biology CrossRef
17. Acute Developmental Toxicity of Panax notoginseng in Zebrafish Larvae
    Rong-rong Wang et al, 2023, Chinese Journal of Integrative Medicine CrossRef
18. Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview
    Lian Duan et al, 2017, Frontiers in Pharmacology CrossRef
19. Jingshu Keli and its Components Notoginsenoside R1 and Ginsenoside Rb1 Alleviate the Symptoms of Cervical Myelopathy through Kir3.1 Mediated Mechanisms
    Renjie Yan et al, 2019, CNS & Neurological Disorders - Drug Targets CrossRef
20. Oxyresveratrol Is a Phytoestrogen Exerting Anti-inflammatory Effects Through NF-κB and Estrogen Receptor Signaling
    Jing Wei et al, 2017, Inflammation CrossRef
21. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms
    Wenxiang Fan et al, 2020, Biomedicine & Pharmacotherapy CrossRef
22. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER
    Gleisy Kelly Goncalves et al, 2018, American Journal of Physiology-Cell Physiology CrossRef
23. Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic–Ischemic Brain Injury
    Liu Tu et al, 2018, Neurochemical Research CrossRef
24. Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review
    Yuhan Ma et al, 2024, Frontiers in Pharmacology CrossRef
25. Efficacy and safety of Panax notoginseng saponin injection in the treatment of acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
    Pengfei Chen et al, 2024, Frontiers in Pharmacology CrossRef
26. Naringin protects against lipopolysaccharide-induced cardiac injury in mice
    Liu Xianchu et al, 2016, Environmental Toxicology and Pharmacology CrossRef
27. PNS-R1 inhibits Dex-induced bronchial epithelial cells apoptosis in asthma through mitochondrial apoptotic pathway
    Wenjing Zou et al, 2019, Cell & Bioscience CrossRef
28. Notoginsenoside R1 inhibits oxidized low-density lipoprotein induced inflammatory cytokines production in human endothelial EA.hy926 cells
    Ping Su et al, 2016, European Journal of Pharmacology CrossRef
29. Notoginsenoside R1 significantly promotes in vitro osteoblastogenesis
    Yi Liu et al, 2016, International Journal of Molecular Medicine CrossRef
30. Advances on hormone-like activity of Panax ginseng and ginsenosides
    Mei TIAN et al, 2020, Chinese Journal of Natural Medicines CrossRef
31. Global analysis of qualitative and quantitative metabolism of Notoginsenoside R1 in rat liver-brain-gut axis based on LC-IT-TOF/MS combing mMDF strategy
    Kangrui Hu et al, 2022, Phytomedicine CrossRef
32. Estrogen and estrogen receptors in kidney diseases
    Hao-Yang Ma et al, 2021, Renal Failure CrossRef
33. RETRACTED: Notoginsenoside R1 suppresses miR-301a via NF-κB pathway in lipopolysaccharide-treated ATDC5 cells
    Yan Dong et al, 2020, Experimental and Molecular Pathology CrossRef
34. Notoginsenoside R1 Protects against Neonatal Cerebral Hypoxic-Ischemic Injury through Estrogen Receptor–Dependent Activation of Endoplasmic Reticulum Stress Pathways
    Yan Wang et al, 2016, The Journal of Pharmacology and Experimental Therapeutics CrossRef
35. Synergistic Effects of Ginsenoside Rb3 and Ferruginol in Ischemia-Induced Myocardial Infarction
    Xu Chen et al, 2022, International Journal of Molecular Sciences CrossRef
36. Notoginsenoside R1 protects oxygen and glucose deprivation‐induced injury by upregulation of miR‐21 in cardiomyocytes
    Zengjia Liu et al, 2019, Journal of Cellular Biochemistry CrossRef
37. Notoginsenoside R1 prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenation via the ERs/PI3K/Akt pathway
    Guang Li et al, 2018, RSC Advances CrossRef
38. Four C-geranyl flavonoids from the flowers of Paulownia fortunei and their anti-inflammatory activity
    Jing-Ke Zhang et al, 2020, Natural Product Research CrossRef
39. The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review
    Zahra Hajializadeh et al, 2022, Heart Failure Reviews CrossRef